The Future of Psychedelic Wellness Tourism

Explore the future of psychedelic wellness tourism, from legally structured retreats to the growing focus on preparation, integration and lasting change.

By Rachel Branson, Founder & Editor in Chief· 15 Nov 2026 · 13 min read
Psychedelic Wellness Tourism
Psychedelic Wellness Tourism

For years, wellness tourism has sold us the promise of feeling better. We travel to spas to rest, retreats to reset and far-flung destinations to escape the pressures of everyday life. We return home perhaps a little lighter, better slept and temporarily inspired to meditate every morning, eat differently or finally establish those healthier habits we have been promising ourselves. Then real life gradually creeps back in.

But what happens when the purpose of a wellness journey is no longer simply to make us feel better while we are away, but deliberately to change something about the way we live when we return?

That was one of the questions at the heart of a fascinating discussion I joined recently, hosted by Jenny Southan, founder and CEO of travel trends forecasting agency Globetrender, alongside Neil Markey, co-founder and CEO of Beckley Retreats, and neuroscientist Dr Grace Blest-Hopley, an advisor to Beckley Retreats. The conversation coincided with Globetrender’s new report, The Future of Psychedelic Wellness Tourism, which explores an emerging area of travel where the boundaries between retreat, hospitality, personal development and healthcare are becoming increasingly difficult to define. 

It is a subject that requires some careful distinction. This is not about recreational drug tourism or suggesting that psychedelics are appropriate for everyone. The discussion focused specifically on structured psychedelic experiences taking place legally within retreat environments, surrounded by screening, preparation, professional facilitation and subsequent integration. 

Yet perhaps the most interesting thing about psychedelic wellness tourism is not psychedelics themselves. It is what this emerging sector reveals about our changing relationship with wellness.

From relaxation to transformation

Globetrender describes a shift towards what it calls the “Transformation Economy”: Affluent consumers increasingly value experiences not simply according to what they do, but according to who they might become as a consequence. In travel terms, that is a profound change. The measure of a successful wellness holiday may eventually be less about how relaxed you felt beside the infinity pool and more about what is demonstrably different six months after you returned home.

Travel has, of course, always been capable of changing us. Pilgrimages, gap years, sabbaticals and journeys taken following bereavement, divorce or retirement have long provided physical distance from our normal lives at moments when we need to reconsider them. What appears to be changing is the intentionality behind that transformation. Rather than hoping that travel might provide clarity, an emerging category of retreat is being deliberately constructed around creating the conditions in which people can examine themselves more deeply.

Psilocybin retreats are perhaps the most intense expression of this idea because the transformation is not an incidental benefit of the trip. It is the reason for going. Preparation begins before arrival, the experience itself takes place within a carefully considered environment, and the work continues afterwards through integration, reflection and behavioural change. 

This raises an interesting question for the wider wellness industry. If a retreat claims to be “transformational”, where does its responsibility to its guest actually end?

Meet the Intentional Seeker

One of the most revealing findings from Globetrender’s research challenges some of the stereotypes surrounding people interested in psychedelics. An analysis of more than 1,200 Beckley Retreats guest records identified what Globetrender calls the “Intentional Seeker”: typically a financially comfortable, high-functioning professional in midlife rather than an experienced psychedelic user.

The typical guest identified in the analysis was aged between 40 and 55, with a median age of 45; 58 per cent were women, while 61 per cent of applicants had never previously taken a psychedelic. Their reasons for attending ranged from personal growth and inner work to burnout, chronic stress, grief, major life transitions, career change, retirement and spiritual exploration. 

That last statistic is particularly interesting. If 61 per cent have never used psychedelics before, this is not simply an existing psychedelic community looking for a luxurious environment in which to have another experience. For some, the professional structure may be precisely the attraction.

Markey described guests who have often already explored therapy, meditation, breathwork and other personal-development practices but feel they are looking for greater depth. They may want to improve relationships, develop gratitude, change entrenched habits or simply understand themselves differently. Others have researched psychedelics but want their first experience to take place legally and within a controlled environment. 

It places psychedelic wellness within a much bigger midlife conversation. What does “well” actually mean when someone is functioning perfectly adequately, yet feels disconnected, stuck or unable to change patterns they know no longer serve them?

Are we only interested in wellbeing once something goes wrong?

This was where Dr Grace Blest-Hopley’s contribution became particularly thought provoking. Much psychedelic research has understandably concentrated on clinical conditions including depression, anxiety and post-traumatic stress disorder. Yet Blest-Hopley questioned the simplicity of dividing people into two neat groups: mentally ill and mentally well.

Human wellbeing rarely behaves so conveniently. Stress, grief, trauma, anxiety and emotional rigidity exist on continuums, and our psychological state fluctuates throughout our lives. The intriguing question therefore becomes whether interventions currently being studied in relation to illness might eventually have a role in preventative wellbeing — not as a replacement for medical treatment, but as part of a wider conversation about resilience and psychological health.

This remains an area where scientific caution matters. Blest-Hopley discussed research into neuroplasticity, connectivity within the brain and potential effects beyond conventional psychiatric endpoints, while also noting that some emerging findings — including areas such as inflammation — remain at earlier stages and may currently rely on animal research. 

As psychedelic wellness moves into a commercial travel environment, scientific excitement should never quietly turn into marketing certainty.

There is nevertheless a fascinating idea here. Much of conventional healthcare remains necessarily focused on treating illness once symptoms reach a level requiring intervention. Wellness, at its most useful, asks what we can do earlier. Markey is currently exploring precisely that question from a public-health perspective: whether experiences and practices that help people develop resilience might ultimately contribute to preventative health. 

Psychedelics may or may not eventually become part of that landscape on any significant scale, but the question they raise is valuable in itself: why do we so often wait for people to become unwell before taking their inner wellbeing seriously?

The myth of the beautiful breakthrough

There is another side of transformational wellness that deserves considerably more attention. Transformation does not necessarily feel good.

The glossy visual language surrounding retreats can easily imply that breakthrough arrives accompanied by sunshine, beautiful landscapes and an overwhelming feeling of enlightenment. Yet the discussion repeatedly challenged what Globetrender calls the “myth of the beautiful breakthrough”.

Southan spoke candidly about her own experience at a Beckley Retreats programme in Jamaica. She had attended primarily through professional curiosity and described herself beforehand as happy and balanced, rather than someone seeking help during a personal crisis. Yet her first psychedelic session became extraordinarily intense. She described feeling immobilised for hours, experiencing powerful emotions, including rage, and emerging from the ceremony feeling “dismantled”. What was particularly revealing was that the significance of her experience did not become immediately apparent. Instead, it was through the months that followed, supported by continued reflection, therapy and coaching, that she began to understand and work through what had surfaced.

This highlights the importance of Beckley Retreats’ structured approach to preparation and integration, which begins well before guests arrive and continues long after they return home. Recognising that many participants are busy professionals with demanding lives, the programme combines preparatory guidance, meditation and self-reflection with post-retreat integration support, including online group sessions, practical exercises and access to additional professional guidance where needed. For Southan, this ongoing process helped her make sense of an experience that initially felt overwhelming, allowing her to continue exploring its meaning within her everyday life. It also illustrates the importance between simply offering a powerful experience and providing the support needed to process it. In a wellness industry often captivated by the promise of instant transformation, perhaps the most meaningful work is not what happens during the retreat itself, but the care, preparation and personal commitment that surround it.

If wellness travel begins deliberately offering experiences capable of making someone psychologically vulnerable, operators acquire a very different responsibility from the traditional hotel or spa. A guest cannot simply be handed a robe, treatment menu and timetable. Screening, psychological, medication and medical considerations matter. The skills of the facilitators matter as does the physical and emotional environment. And what happens after the guest gets on the plane home matters enormously.

Markey explained that Beckley Retreats screens applicants and does not position its programmes as treatment for conditions such as PTSD or treatment-resistant depression. Some applicants are declined, with the organisation attempting to direct people towards more appropriate support where necessary. He also highlighted particular concerns around severe psychiatric conditions and the possibility that psychedelic experiences can be destabilising for some individuals. 

The wider industry will have to confront this issue as demand grows because standards currently vary significantly between retreat operators. There is not yet a single central governing body setting universal standards for psychedelic retreats, and Markey acknowledged that greater professionalisation and standardisation will be needed. Growth without governance could prove to be one of the sector’s greatest risks.

When luxury means feeling safe

There was one phrase from the Globetrender presentation that particularly stayed with me: “Integration is the new luxury.”

It challenges almost everything the hospitality industry traditionally associates with the word.

Luxury isn’t necessarily marble bathrooms, enormous suites or champagne waiting on arrival. It might mean knowing that the person sitting beside you is sufficiently trained to recognise when something is wrong. It might mean rigorous screening before anyone accepts your booking. It might mean beautiful natural surroundings designed to create psychological safety. And, crucially, it might mean knowing someone will still be there after you return home. 

At Beckley Retreats, formal integration continues digitally for six weeks after the retreat through group calls, practical exercises and continued practices such as meditation, mindful movement, time in nature and gratitude work. Guests who need individual support may access further sessions, while those with existing therapists are encouraged to bring those professionals into the process. 

Blest-Hopley described the importance of creating a “landing pad” before the psychedelic experience has even taken place. Her point was that the aftermath should not be an afterthought. If difficult material surfaces, or if someone returns home determined to change an entrenched behaviour or relationship, support should already be available to help translate insight into everyday life.

Imagine if a weight-management retreat maintained meaningful contact for several months after departure. Imagine if a sleep retreat worked with guests once they were back in the bedroom where their insomnia actually occurs. Imagine if a burnout programme continued supporting someone when they returned to the workplace that contributed to their exhaustion.

Perhaps the future of luxury wellness isn’t providing ever more elaborate experiences. Perhaps it is taking greater responsibility for whether those experiences actually make a difference.

When does hospitality become healthcare?

This evolution also creates an uncomfortable question for hotels and wellness destinations.

Where does hospitality end and healthcare begin?

We are already watching luxury wellness move towards medicine through longevity clinics, genetic analysis, diagnostic testing, hormone assessment, cognitive optimisation and increasingly sophisticated health screening. Psychedelic retreats make that convergence even more obvious because the environment itself is considered part of what practitioners refer to as the “container”: accommodation, nature, nutrition, sleep, ritual, creativity, therapeutic expertise and human care collectively influence the experience. 

Blest-Hopley argued that acute mental-health crises clearly belong within established clinical systems, while longer-term preventative wellbeing may require us to think more imaginatively about environments capable of providing time, community and sustained support. She also highlighted something conventional wellness sometimes overlooks: community itself can be an important component of wellbeing. 

It is tempting to imagine the solution is simply to medicalise everything. Yet doing so could potentially remove some of the qualities that make retreats valuable in the first place.

Markey spoke about the importance of “set and setting” and the role of nature, human relationships and the individuality of an experience. Beckley Retreats co-founder Amanda Feilding, he recalled, was determined that the organisation should not become the “Starbucks of psychedelics”: a standardised, cookie-cutter experience replicated identically everywhere. 

There lies perhaps the industry’s biggest challenge: how do you standardise safety without standardising humanity?

A new responsibility for wellness travel

Globetrender’s report considers several possible futures. Psychedelic wellness could become an established part of luxury hospitality; tighter medicalisation could keep access predominantly within licensed clinical environments; alternatively, safety incidents or political opposition could restrict the sector and potentially push elements of it underground. The report’s proposed direction sits somewhere between expansion and discipline, with increasing regulation and credibility becoming increasingly important. 

It is worth noting that Beckley Retreats operates its programmes in Jamaica and the Netherlands because their legal frameworks permit carefully structured psilocybin experiences, unlike the United States, where psilocybin remains illegal under federal law despite growing moves towards reform at state level. However, legality is not the same as comprehensive regulation, and the rules differ significantly between destinations. As the science advances and attitudes begin to shift, the question of where and how these experiences can be offered responsibly will become increasingly important. Whatever happens, psychedelic wellness tourism is prompting the wider wellness industry to confront questions about safety, accountability and the true meaning of transformation that have been building for some time.

What are we actually promising when we use the word transformation? If an experience opens something psychologically significant, who is responsible for helping someone process it? Should wellness businesses be expected to demonstrate outcomes rather than simply provide experiences? At what point does personal optimisation become healthcare? And as increasingly sophisticated interventions move from hospitals into retreats and hotels, who decides what constitutes sufficient expertise, evidence and care?

Perhaps most importantly, we should be cautious about turning psychedelics into wellness’s next fashionable ingredient. The history, science, cultural traditions and psychological complexity surrounding these substances deserve more than a luxury rebrand.

Yet there is something valuable happening underneath the hype.

For decades, much of wellness tourism has been built around temporary escape: leave your stressful life, enter a beautiful environment, feel better for a few days and then go home. Psychedelic retreats represent a far more demanding proposition. They ask travellers to participate rather than simply receive, to prepare before arriving and to continue the work long after leaving. And perhaps that is the real future of transformational travel.

Not where every luxury resort begins offering psychedelics, but one in which the entire wellness industry starts thinking differently about what happens after checkout.

Because ultimately the most meaningful measure of a wellbeing retreat may not be how we feel while we are there, but how we live differently when we come home.

DISCOVER: beckleyretreats.com

Filed underCaribbean, Retreat

Share this story
Rachel Branson

About the author

Rachel Branson

Founder & Editor in Chief

With over 30 years in publishing and a background in Naturopathic Medicine, she has made it her mission to challenge mainstream health narratives and empower people to take control of their wellbeing. Now expanding her vision across the Atlantic, Rachel is bridging UK and US audiences with inspiring stories, trusted insights, and pioneering partnerships that align with a new era of health innovation.

You might also like

Newsletter

Good things, in your inbox.

Thoughtful stories, new perspectives and wellbeing inspiration — monthly.